Press Release – updated: Sep 9, 2020 10:00 EDT
ORLANDO, Fla., September 9, 2020 (Newswire.com) – Therigy®, the trusted partner for specialty pharmacy therapy management software and services, announced today that its team will be presenting the following at the 2020 NASP Annual Meeting and Expo:
An abstract Impact of Specialty Pharmacies on Stomatitis Prophylaxis with Dexamethasone at Everolimus Therapy Initiation; a case study in the Innovation Lab series: Mobile-Enabled Patient Messaging Increases Patient Contact Rates and PDC, and speak on the State of Care 2020: Oral Oncology panel along with Joseph Barone, PharmD, BCOP, Onco360, and Allison Kinnarney, BA, BSN, RN, Biologics by McKesson.
Conducted by the National Association of Specialty Pharmacy, the 2020 NASP Annual Meeting & Expo is being held virtually from Sept. 14-18. The event is an opportunity for senior hospital executives, pharmacy directors, staff pharmacists, consultants, and other management-level personnel from specialty pharmacy providers to share best practices, foster partnerships and synergies, and celebrate what is special about specialty pharmacy. Details on the three presentations are as follows:
(1) Abstract: Lily Duong, PharmD, Khang Tran, PharmD, and Abbas Dewji, PharmD, will present the abstract Impact of Specialty Pharmacies on Stomatitis Prophylaxis with Dexamethasone at Everolimus Therapy Initiation on Wednesday, Sept. 16, 12:30 – 2:00 P.M. ET
(2) Case study: Lily Duong, PharmD and Nicole Hasson, PharmD, Value Specialty Pharmacy, will present Mobile-Enabled Patient Messaging Improves PDC and Patient Contact Rates as part of Technology Day in the Innovation Lab on Monday, Sept. 14, 1:00 – 2:30 P.M. ET
(3) Panel presentation: The Site of Care 2020: Oral Oncology panel is scheduled for Thursday, Sept. 17 at 3:30 pm – 4:30 P.M. ET with Dr. Duong speaking as a member of the panel.
For more information, visit NASPmeeting.com.
“The NASP event provides an important opportunity to examine current standards of care within specialty disease areas and examine best practices for clinically managing specialty patients,” said Joe Morse, President, Therigy. “It is a great honor for our team to present at this prestigious specialty pharmacy meeting.”
An industry pioneer, Therigy® leads the specialty pharmacy market with patient-focused specialty therapy management solutions. Therigy serves over one million active patients and eight thousand subscribers nationwide. By equipping pharmacy stakeholders with the tools to standardize and scale patient management programs, Therigy ensures a depth and consistency of clinical care never before possible. Therigy helps clients to grow their patient population, deliver value-based outcomes, gain insights into evolving patient needs, and predict therapy trends. Learn more about Therigy: therigy.com